{"date_created":"2011-01-25","rcv_accession_id":"RCV000013444","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"3","clinical_assertion_observation_ids":["SCV000033691.0"],"variation_id":"12610","interpretation_date_last_evaluated":"2008-03-15","submission_id":"3.2010-12-30","clinical_assertion_trait_set_id":"SCV000033691","interpretation_comments":[],"local_key":"190020.0011_COSTELLO SYNDROME","id":"SCV000033691","variation_archive_id":"VCV000012610","internal_id":"33691","version":"2","title":"HRAS, THR58ILE_COSTELLO SYNDROME","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"3420","review_status":"no assertion criteria provided","submission_names":[]}
{"date_created":"2017-12-15","rcv_accession_id":"RCV000013444","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"506439","clinical_assertion_observation_ids":["SCV000616365.0"],"variation_id":"12610","submitted_assembly":"GRCh38","interpretation_date_last_evaluated":"2017-04-03","submission_id":"506439.2019-02-25","clinical_assertion_trait_set_id":"SCV000616365","interpretation_comments":["{\"text\":\"The c.173C\u003eT (p.Thr58Ile) variant in HRAS has been reported in the literature as an unconfirmed de novo occurrence in a patient with clinical features of a RASopathy (PM6; PMID 20112233, 16474405). Also, at least 2 independent occurrences of this variant have been detected in patients with a RASopathy (PS4_Supporting; PMID: 22488832, 18247425, 23321623, 20949621, 16921267). This variant was absent from large population studies (PM2; ExAC, http://exac.broadinstitute.org). The p.Thr58Ile variant in HRAS is analogous to the same previously established amino acid change in the KRAS gene and the ClinGen RASopathy Expert Panel has defined that the pathogenicities of analogous variants in the HRAS and KRAS genes are correlated based on the assumption that a known functional residue in one gene is equivalent to other functions within that subgroup (PS1; 29493581). Furthermore, the variant is in a location that has been defined by the ClinGen RASopathy Expert Panel to be a mutational hotspot or domain of HRAS (PM1; PMID 29493581). The variant is in HRAS, which has been defined by the ClinGen RASopathy Expert Panel as a gene with low rate of benign missense with missense variants commonly being pathogenic (PP2; PMID 29493581). Computational prediction tools and conservation analysis suggest that the p.Thr58Ile variant may impact the protein (PP3). In summary, this variant meets criteria to be classified as pathogenic for RASopathies in an autosomal dominant manner. Rasopathy-specific ACMG/AMP criteria applied (PMID:29493581): PM6, PS4_Supporting, PM2, PS1, PM1, PP2, PP3.\",\"type\":\"public\"}"],"content":"{\"@FDARecognizedDatabase\":\"true\",\"AttributeSet\":[{\"Attribute\":{\"$\":\"Autosomal dominant inheritance\",\"@Type\":\"ModeOfInheritance\"}},{\"Attribute\":{\"$\":\"ClinGen RASopathy ACMG Specifications v1\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/60rptlbs/clingen_rasopathy_acmg_specifications_v1.pdf\"}}}],\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"20949621\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16474405\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20112233\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16921267\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22488832\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23321623\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18247425\",\"@Source\":\"PubMed\"}},{\"URL\":{\"$\":\"https://erepo.clinicalgenome.org/evrepo/ui/interpretation/4fa14d9d-3bce-4dd8-affa-771b6298c4fc\"}}]}}","local_key":"4fa14d9d-3bce-4dd8-affa-771b6298c4fc|Orphanet:ORPHA3071","id":"SCV000616365","variation_archive_id":"VCV000012610","internal_id":"1202773","version":"3","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"3420","review_status":"reviewed by expert panel","submission_names":["SUB5222244"]}
{"date_created":"2013-03-16","rcv_accession_id":"RCV000013444","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"21766","clinical_assertion_observation_ids":["SCV000062127.0"],"variation_id":"12610","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2014-09-23","submission_id":"21766.2018-02-23","clinical_assertion_trait_set_id":"SCV000062127","interpretation_comments":["{\"text\":\"The Thr58Ile variant in HRAS has been reported in three individuals with clinical features of Costello syndrome (Gripp 2008, Gripp 2012, LMM unpublished data). It was identified to occur de novo in two of these individuals and segregated with disease in one affected relative from one of these families. This variant was absent from large population studies. Computational prediction tools and conservation analysis suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In summary, this variant meets our criteria to be classified as pathogenic (http://pcpgm.partners.org/LMM).\",\"type\":\"public\"}"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"LMM Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"24033266\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"22488832\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18247425\",\"@Source\":\"PubMed\"}}]}}","local_key":"26351883|OMIM:218040","id":"SCV000062127","variation_archive_id":"VCV000012610","internal_id":"103327","version":"5","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"3420","review_status":"criteria provided, single submitter","submission_names":["SUB3719835"]}
{"date_created":"2013-11-19","rcv_accession_id":"RCV000003697","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"256489","clinical_assertion_observation_ids":["SCV000106043.0"],"variation_id":"3520","submitted_assembly":"not applicable","submission_id":"256489.2017-03-08","clinical_assertion_trait_set_id":"SCV000106043","interpretation_comments":[],"local_key":"NM_005957.4:c.665C\u003eT|MedGen:C1856059","id":"SCV000106043","variation_archive_id":"VCV000003520","internal_id":"183447","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"916","review_status":"no assertion criteria provided","submission_names":["FirmaLab_clinical_tests_from_GTR"]}
{"date_created":"2014-11-11","rcv_accession_id":"RCV000144921","record_status":"current","interpretation_description":"Uncertain significance","submitter_id":"505267","clinical_assertion_observation_ids":["SCV000187678.0"],"variation_id":"3520","submission_id":"505267.2014-07-16","clinical_assertion_trait_set_id":"SCV000187678","interpretation_comments":[],"content":"{\"Citation\":[{\"@Type\":\"general\",\"ID\":{\"$\":\"25227144\",\"@Source\":\"PubMed\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"25227144\",\"@Source\":\"PubMed\"}}],\"Interpretation\":{\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"25227144\",\"@Source\":\"PubMed\"}}}}","local_key":"rs1801133","id":"SCV000187678","variation_archive_id":"VCV000003520","internal_id":"339358","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"6607","review_status":"no assertion criteria provided","submission_names":[]}
{"date_created":"2017-03-02","rcv_accession_id":"RCV000427078","record_status":"current","interpretation_description":"not provided","submitter_id":"505871","clinical_assertion_observation_ids":["SCV000505736.0"],"variation_id":"3520","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-03-10","submission_id":"505871.2016-07-18","clinical_assertion_trait_set_id":"SCV000505736","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Somatic mutation\",\"@Type\":\"ModeOfInheritance\"}},\"Citation\":{\"URL\":{\"$\":\"http://docm.genome.wustl.edu/variants/ENST00000376592:c.665C\u003eT\"}},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"18704422\",\"@Source\":\"PubMed\"}}},\"StudyDescription\":{\"$\":\"This is the initial submission of DoCM to ClinVar. DoCM is the database of curated mutations in cancer and seeks to leverage the community to outline all functionally important somatic cancer variants in the literature.\"}}","local_key":"ENST00000376592:c.665C\u003eT|MeSH:D013274","id":"SCV000505736","variation_archive_id":"VCV000003520","internal_id":"971011","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"6728","review_status":"no assertion provided","submission_names":["DoCM_7-13-16"]}
{"date_created":"2016-12-02","rcv_accession_id":"RCV000259890","record_status":"current","interpretation_description":"Likely benign","submitter_id":"504895","clinical_assertion_observation_ids":["SCV000347807.0"],"variation_id":"3520","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-06-14","submission_id":"504895.2016-10-18","clinical_assertion_trait_set_id":"SCV000347807","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification 20161018\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"ICSL_Variant_Classification_20161018.pdf\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/4jQgNGYk/ICSL_Variant_Classification_20161018.pdf\"}}}}","local_key":"361|Neural Tube Defects, Folate-Sensitive","id":"SCV000347807","variation_archive_id":"VCV000003520","internal_id":"661330","version":"2","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"6564","review_status":"criteria provided, single submitter","submission_names":["ICSL_2016Q4"]}
{"date_created":"2016-05-18","rcv_accession_id":"RCV000211336","record_status":"current","interpretation_description":"drug response","submitter_id":"500295","clinical_assertion_observation_ids":["SCV000268238.0"],"variation_id":"3520","submitted_assembly":"GRCh38","interpretation_date_last_evaluated":"2016-07-11","submission_id":"500295.2018-06-18","clinical_assertion_trait_set_id":"SCV000268238","interpretation_comments":["{\"text\":\"PharmGKB Level of Evidence 2A: Annotation for a variant-drug combination that qualifies for level 2B where the variant is within a VIP (Very Important Pharmacogene) as defined by PharmGKB. The variants in level 2A are in known pharmacogenes, so functional significance is more likely.\",\"type\":\"public\"}"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Pharmacogenomics knowledge for personalized medicine\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"22992668\",\"@Source\":\"PubMed\"}}},\"Citation\":{\"URL\":{\"$\":\"https://www.pharmgkb.org/clinicalAnnotation/981220481\"}},\"Comment\":{\"$\":\"Drug is not necessarily used to treat response condition\",\"@Type\":\"public\"},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"19307503\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"21605004\",\"@Source\":\"PubMed\"}}],\"ExplanationOfInterpretation\":{\"$\":\"Drug-variant association: Efficacy\"}}}","local_key":"981220481PA448803|carboplatin response - Efficacy","id":"SCV000268238","variation_archive_id":"VCV000003520","internal_id":"503705","version":"3","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"26870","review_status":"reviewed by expert panel","submission_names":["PharmGKB-ClinVar 2018-05"]}
{"date_created":"2016-05-18","rcv_accession_id":"RCV000211133","record_status":"current","interpretation_description":"drug response","submitter_id":"500295","clinical_assertion_observation_ids":["SCV000268236.0"],"variation_id":"3520","submitted_assembly":"GRCh38","interpretation_date_last_evaluated":"2016-07-11","submission_id":"500295.2018-06-18","clinical_assertion_trait_set_id":"SCV000268236","interpretation_comments":["{\"text\":\"PharmGKB Level of Evidence 2A: Annotation for a variant-drug combination that qualifies for level 2B where the variant is within a VIP (Very Important Pharmacogene) as defined by PharmGKB. The variants in level 2A are in known pharmacogenes, so functional significance is more likely.\",\"type\":\"public\"}"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Pharmacogenomics knowledge for personalized medicine\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"22992668\",\"@Source\":\"PubMed\"}}},\"Citation\":{\"URL\":{\"$\":\"https://www.pharmgkb.org/clinicalAnnotation/981204929\"}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"15051775\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"19159907\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20638924\",\"@Source\":\"PubMed\"}}],\"ExplanationOfInterpretation\":{\"$\":\"Drug-variant association: Toxicity/ADR\"}}}","local_key":"981204929PA449165|cyclophosphamide response - Toxicity/ADR","id":"SCV000268236","variation_archive_id":"VCV000003520","internal_id":"503703","version":"3","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"26869","review_status":"reviewed by expert panel","submission_names":["PharmGKB-ClinVar 2018-05"]}
{"date_created":"2017-03-03","rcv_accession_id":"RCV000428048","record_status":"current","interpretation_description":"Benign","submitter_id":"26957","clinical_assertion_observation_ids":["SCV000519504.0"],"variation_id":"3520","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-04-25","submission_id":"26957.2018-03-26","clinical_assertion_trait_set_id":"SCV000519504","interpretation_comments":["{\"text\":\"This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.\",\"type\":\"public\"}"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"GeneDX Variant Classification (06012015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/7oynscmk/mdi-5616_26957_genedx_interprules_final_061215.pdf\"}}}}","local_key":"GDX:570299|Not Provided","id":"SCV000519504","variation_archive_id":"VCV000003520","internal_id":"984917","version":"4","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"9590","review_status":"criteria provided, single submitter","submission_names":["SUB3839901"]}
{"date_created":"2019-03-28","record_status":"current","interpretation_description":"Uncertain significance","submitter_id":"500105","clinical_assertion_observation_ids":["SCV000895101.0"],"variation_id":"37594","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2018-10-31","submission_id":"500105.2018-11-14","clinical_assertion_trait_set_id":"SCV000895101","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}},\"Citation\":{\"@Abbrev\":\"ACMG, 2015\",\"@Type\":\"practice guideline\",\"ID\":[{\"$\":\"25741868\",\"@Source\":\"PubMed\"},{\"$\":\"10.1038/gim.2015.30\",\"@Source\":\"DOI\"}]}}","local_key":":Chr.17_41251893_41251893_T_G|OMIM:114480;604370;614320;617883","id":"SCV000895101","variation_archive_id":"VCV000037594","internal_id":"1751540","version":"1","date_last_updated":"2019-05-02","assertion_type":"variation to disease","review_status":"criteria provided, single submitter","submission_names":["SUB4786732"]}
{"date_created":"2016-03-15","record_status":"current","interpretation_description":"Uncertain significance","submitter_id":"505720","clinical_assertion_observation_ids":["SCV000265873.0"],"variation_id":"37594","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2015-11-01","submission_id":"505720.2016-02-27","clinical_assertion_trait_set_id":"SCV000265873","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}},\"Citation\":[{\"@Type\":\"general\",\"ID\":{\"$\":\"27257965\",\"@Source\":\"PubMed\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"27257965\",\"@Source\":\"PubMed\"}}],\"Interpretation\":{\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"27257965\",\"@Source\":\"PubMed\"}}}}","local_key":"NM_007294.3:c.446A\u003eC|MedGen:CN221572","id":"SCV000265873","variation_archive_id":"VCV000037594","internal_id":"498108","version":"1","date_last_updated":"2019-05-02","assertion_type":"variation to disease","review_status":"criteria provided, single submitter","submission_names":["Chinese507BC_BRCA"]}
{"date_created":"2018-04-04","rcv_accession_id":"RCV000039762","record_status":"current","interpretation_description":"Likely benign","submitter_id":"26957","clinical_assertion_observation_ids":["SCV000729392.0"],"variation_id":"46503","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2017-11-21","submission_id":"26957.2018-03-26","clinical_assertion_trait_set_id":"SCV000729392","interpretation_comments":["{\"text\":\"This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.\",\"type\":\"public\"}"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"GeneDX Variant Classification (06012015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/7oynscmk/mdi-5616_26957_genedx_interprules_final_061215.pdf\"}}}}","local_key":"GDX:46979|Not Provided","id":"SCV000729392","variation_archive_id":"VCV000046503","internal_id":"1410550","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"9590","review_status":"criteria provided, single submitter","submission_names":["SUB3839901"]}
{"date_created":"2018-03-28","rcv_accession_id":"RCV000727222","record_status":"current","interpretation_description":"Uncertain significance","submitter_id":"500060","clinical_assertion_observation_ids":["SCV000706730.0"],"variation_id":"46503","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2018-05-30","submission_id":"500060.2018-09-19","clinical_assertion_trait_set_id":"SCV000706730","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"EGL_ClinVar_v180209_classification definitions\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/leconafi/egl_clinvar_v180209_classification_definitions.pdf\"}}},\"Citation\":{\"URL\":{\"$\":\"http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=PCDH15\"}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"}}","local_key":"60128_000000","id":"SCV000706730","variation_archive_id":"VCV000046503","internal_id":"1379128","version":"2","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"9460","review_status":"criteria provided, single submitter","submission_names":["SUB4534263"]}
{"date_created":"2018-03-28","rcv_accession_id":"RCV000726979","record_status":"current","interpretation_description":"Uncertain significance","submitter_id":"500060","clinical_assertion_observation_ids":["SCV000704632.0"],"variation_id":"48176","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-12-20","submission_id":"500060.2018-09-19","clinical_assertion_trait_set_id":"SCV000704632","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"EGL_Classification_Definitions_2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/dn5yhybg/egl_classification_definitions_2015.pdf\"}}},\"Citation\":{\"URL\":{\"$\":\"http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=OTOF\"}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"}}","local_key":"57851_000000","id":"SCV000704632","variation_archive_id":"VCV000048176","internal_id":"1377031","version":"2","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"9460","review_status":"criteria provided, single submitter","submission_names":["SUB4534263"]}
{"date_created":"2014-02-18","rcv_accession_id":"RCV000078671","record_status":"current","interpretation_description":"not provided","submitter_id":"500304","clinical_assertion_observation_ids":["SCV000117933.0"],"variation_id":"7884","submission_id":"500304.2012-12-20","clinical_assertion_trait_set_id":"SCV000117933","interpretation_comments":[],"content":"{\"Comment\":{\"$\":\"http://phencode.bx.psu.edu/cgi-bin/phencode/phencode?build=hg19\u0026id=RISN_ABCR:c.6148G\u003eC\",\"@Type\":\"public\"}}","local_key":"RISN-ABCR:c.6148G\u003eC","id":"SCV000117933","variation_archive_id":"VCV000007884","internal_id":"205773","version":"1","date_last_updated":"2019-04-19","assertion_type":"variation to disease","trait_set_id":"9460","review_status":"no assertion provided","submission_names":["RISN_LSDB_112012"]}
{"date_created":"2017-09-07","rcv_accession_id":"RCV000504806","record_status":"current","interpretation_description":"Likely pathogenic","submitter_id":"505998","clinical_assertion_observation_ids":["SCV000599010.0"],"variation_id":"7884","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2015-01-01","submission_id":"505998.2017-08-18","clinical_assertion_trait_set_id":"SCV000599010","interpretation_comments":[],"content":"{\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"28041643\",\"@Source\":\"PubMed\"}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"9054934\",\"@Source\":\"PubMed\"}}}}","local_key":"c.6148G\u003eC_HP:0000548","id":"SCV000599010","variation_archive_id":"VCV000007884","internal_id":"1160860","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"33742","review_status":"no assertion criteria provided","submission_names":["NIHR_Bioresource_Rare_Diseases_Retinal_Dystrophy"]}
{"date_created":"2016-12-02","rcv_accession_id":"RCV000340261","record_status":"current","interpretation_description":"Likely benign","submitter_id":"504895","clinical_assertion_observation_ids":["SCV000359225.0"],"variation_id":"7884","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-06-14","submission_id":"504895.2016-10-18","clinical_assertion_trait_set_id":"SCV000359225","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification 20161018\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"ICSL_Variant_Classification_20161018.pdf\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/4jQgNGYk/ICSL_Variant_Classification_20161018.pdf\"}}}}","local_key":"293398|Stargardt Disease, Recessive","id":"SCV000359225","variation_archive_id":"VCV000007884","internal_id":"672747","version":"2","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"33430","review_status":"criteria provided, single submitter","submission_names":["ICSL_2016Q4"]}
{"date_created":"2016-12-02","rcv_accession_id":"RCV000393715","record_status":"current","interpretation_description":"Likely benign","submitter_id":"504895","clinical_assertion_observation_ids":["SCV000359223.0"],"variation_id":"7884","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-06-14","submission_id":"504895.2016-10-18","clinical_assertion_trait_set_id":"SCV000359223","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification 20161018\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"ICSL_Variant_Classification_20161018.pdf\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/4jQgNGYk/ICSL_Variant_Classification_20161018.pdf\"}}}}","local_key":"293398|Retinitis Pigmentosa, Recessive","id":"SCV000359223","variation_archive_id":"VCV000007884","internal_id":"672745","version":"2","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"33382","review_status":"criteria provided, single submitter","submission_names":["ICSL_2016Q4"]}
{"date_created":"2016-12-02","rcv_accession_id":"RCV000393726","record_status":"current","interpretation_description":"Likely benign","submitter_id":"504895","clinical_assertion_observation_ids":["SCV000359226.0"],"variation_id":"7884","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-06-14","submission_id":"504895.2016-10-18","clinical_assertion_trait_set_id":"SCV000359226","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification 20161018\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"ICSL_Variant_Classification_20161018.pdf\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/4jQgNGYk/ICSL_Variant_Classification_20161018.pdf\"}}}}","local_key":"293398|Macular Degeneration","id":"SCV000359226","variation_archive_id":"VCV000007884","internal_id":"672748","version":"2","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"33398","review_status":"criteria provided, single submitter","submission_names":["ICSL_2016Q4"]}
{"date_created":"2016-06-16","rcv_accession_id":"RCV000008335","record_status":"current","interpretation_description":"Likely pathogenic","submitter_id":"505832","clinical_assertion_observation_ids":["SCV000281950.0"],"variation_id":"7884","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-01-01","submission_id":"505832.2016-05-25","clinical_assertion_trait_set_id":"SCV000281950","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Schulz et al. (Invest Ophthalmol Vis Sci. 2017)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"28118664\",\"@Source\":\"PubMed\"}}},\"Citation\":[{\"@Type\":\"general\",\"ID\":{\"$\":\"28118664\",\"@Source\":\"PubMed\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"28118664\",\"@Source\":\"PubMed\"}}],\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"9054934\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23940504\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20335603\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16103129\",\"@Source\":\"PubMed\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"28118664\",\"@Source\":\"PubMed\"}}]}}","local_key":"162","id":"SCV000281950","variation_archive_id":"VCV000007884","internal_id":"533093","version":"2","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"1448","review_status":"criteria provided, single submitter","submission_names":["STGD2016"]}
{"date_created":"2017-03-03","rcv_accession_id":"RCV000078671","record_status":"current","interpretation_description":"Uncertain significance","submitter_id":"26957","clinical_assertion_observation_ids":["SCV000511911.0"],"variation_id":"7884","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2018-11-07","submission_id":"26957.2019-01-29","clinical_assertion_trait_set_id":"SCV000511911","interpretation_comments":["{\"text\":\"The V2050L variant in the ABCA4 gene has been reported previously in association with Stargardt disease, macular dystrophy, cone-rod dystrophy, and age-related macular degeneration (Lewis et al., 1999; Wiszniewski et al., 2005; Poloschek et al., 2010; Fritsche et al., 2012; Corton et al., 2013). Poloschek et al. (2010) reported that V2050L heterozygous carriers show centrally reduced mfERG amplitudes and additional minor fundus abnormalities, which suggested that the V2050L variant in the heterozygous state is capable of mildly reducing macular function without an additional pathogenic variant on the second allele. However, the V2050L variant is observed in 202/34420 (0.5869%) alleles from individuals of Latino background and 787/277174 (0.2839%) global alleles, with one homozygote reported (Lek et al., 2016). The V2050L variant is a conservative amino acid substitution, which occurs at a position that is conserved across species. In-silico analyses, including protein predictors and evolutionary conservation, support that this variant does not alter protein structure/function. We interpret V2050L as a variant of uncertain significance.\",\"type\":\"public\"}"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"GeneDx Variant Classification (06012015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/7oynscmk/mdi-5616_26957_genedx_interprules_final_061215.pdf\"}}}}","local_key":"GDX:874|Not Provided","id":"SCV000511911","variation_archive_id":"VCV000007884","internal_id":"977225","version":"3","date_last_updated":"2019-05-09","assertion_type":"variation to disease","trait_set_id":"9460","review_status":"criteria provided, single submitter","submission_names":["SUB5098196"]}
{"date_created":"2017-03-02","rcv_accession_id":"RCV000443065","record_status":"current","interpretation_description":"Likely pathogenic","submitter_id":"505871","clinical_assertion_observation_ids":["SCV000504294.0"],"variation_id":"13972","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-05-31","submission_id":"505871.2016-07-18","clinical_assertion_trait_set_id":"SCV000504294","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Somatic mutation\",\"@Type\":\"ModeOfInheritance\"}},\"Citation\":{\"URL\":{\"$\":\"http://docm.genome.wustl.edu/variants/ENST00000288602:c.1781A\u003eG\"}},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"26619011\",\"@Source\":\"PubMed\"}}},\"StudyDescription\":{\"$\":\"This is the initial submission of DoCM to ClinVar. DoCM is the database of curated mutations in cancer and seeks to leverage the community to outline all functionally important somatic cancer variants in the literature.\"}}","local_key":"ENST00000288602:c.1781A\u003eG|MeSH:D001932","id":"SCV000504294","variation_archive_id":"VCV000013972","internal_id":"969570","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"11864","review_status":"no assertion criteria provided","submission_names":["DoCM_7-13-16"]}
{"date_created":"2017-03-02","rcv_accession_id":"RCV000423919","record_status":"current","interpretation_description":"Likely pathogenic","submitter_id":"505871","clinical_assertion_observation_ids":["SCV000504292.0"],"variation_id":"13972","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-05-31","submission_id":"505871.2016-07-18","clinical_assertion_trait_set_id":"SCV000504292","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Somatic mutation\",\"@Type\":\"ModeOfInheritance\"}},\"Citation\":{\"URL\":{\"$\":\"http://docm.genome.wustl.edu/variants/ENST00000288602:c.1781A\u003eG\"}},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"26619011\",\"@Source\":\"PubMed\"}}},\"StudyDescription\":{\"$\":\"This is the initial submission of DoCM to ClinVar. DoCM is the database of curated mutations in cancer and seeks to leverage the community to outline all functionally important somatic cancer variants in the literature.\"}}","local_key":"ENST00000288602:c.1781A\u003eG|MeSH:C562393","id":"SCV000504292","variation_archive_id":"VCV000013972","internal_id":"969568","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"6369","review_status":"no assertion criteria provided","submission_names":["DoCM_7-13-16"]}
{"date_created":"2017-03-02","rcv_accession_id":"RCV000418680","record_status":"current","interpretation_description":"Likely pathogenic","submitter_id":"505871","clinical_assertion_observation_ids":["SCV000504300.0"],"variation_id":"13972","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-05-31","submission_id":"505871.2016-07-18","clinical_assertion_trait_set_id":"SCV000504300","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Somatic mutation\",\"@Type\":\"ModeOfInheritance\"}},\"Citation\":{\"URL\":{\"$\":\"http://docm.genome.wustl.edu/variants/ENST00000288602:c.1781A\u003eG\"}},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"26619011\",\"@Source\":\"PubMed\"}}},\"StudyDescription\":{\"$\":\"This is the initial submission of DoCM to ClinVar. DoCM is the database of curated mutations in cancer and seeks to leverage the community to outline all functionally important somatic cancer variants in the literature.\"}}","local_key":"ENST00000288602:c.1781A\u003eG|MeSH:D015451","id":"SCV000504300","variation_archive_id":"VCV000013972","internal_id":"969576","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"9305","review_status":"no assertion criteria provided","submission_names":["DoCM_7-13-16"]}
{"date_created":"2017-03-02","rcv_accession_id":"RCV000435875","record_status":"current","interpretation_description":"Likely pathogenic","submitter_id":"505871","clinical_assertion_observation_ids":["SCV000504299.0"],"variation_id":"13972","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-05-31","submission_id":"505871.2016-07-18","clinical_assertion_trait_set_id":"SCV000504299","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Somatic mutation\",\"@Type\":\"ModeOfInheritance\"}},\"Citation\":{\"URL\":{\"$\":\"http://docm.genome.wustl.edu/variants/ENST00000288602:c.1781A\u003eG\"}},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"26619011\",\"@Source\":\"PubMed\"}}},\"StudyDescription\":{\"$\":\"This is the initial submission of DoCM to ClinVar. DoCM is the database of curated mutations in cancer and seeks to leverage the community to outline all functionally important somatic cancer variants in the literature.\"}}","local_key":"ENST00000288602:c.1781A\u003eG|MeSH:C535575","id":"SCV000504299","variation_archive_id":"VCV000013972","internal_id":"969575","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"1717","review_status":"no assertion criteria provided","submission_names":["DoCM_7-13-16"]}
{"date_created":"2017-03-02","rcv_accession_id":"RCV000426107","record_status":"current","interpretation_description":"Likely pathogenic","submitter_id":"505871","clinical_assertion_observation_ids":["SCV000504298.0"],"variation_id":"13972","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-05-31","submission_id":"505871.2016-07-18","clinical_assertion_trait_set_id":"SCV000504298","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Somatic mutation\",\"@Type\":\"ModeOfInheritance\"}},\"Citation\":{\"URL\":{\"$\":\"http://docm.genome.wustl.edu/variants/ENST00000288602:c.1781A\u003eG\"}},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"26619011\",\"@Source\":\"PubMed\"}}},\"StudyDescription\":{\"$\":\"This is the initial submission of DoCM to ClinVar. DoCM is the database of curated mutations in cancer and seeks to leverage the community to outline all functionally important somatic cancer variants in the literature.\"}}","local_key":"ENST00000288602:c.1781A\u003eG|MeSH:C538231","id":"SCV000504298","variation_archive_id":"VCV000013972","internal_id":"969574","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"3349","review_status":"no assertion criteria provided","submission_names":["DoCM_7-13-16"]}
{"date_created":"2011-01-25","rcv_accession_id":"RCV000015006","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"3","clinical_assertion_observation_ids":["SCV000035262.0"],"variation_id":"13972","interpretation_date_last_evaluated":"2003-11-17","submission_id":"3.2010-12-30","clinical_assertion_trait_set_id":"SCV000035262","interpretation_comments":[],"local_key":"164757.0011_LYMPHOMA, NON-HODGKIN, SOMATIC","id":"SCV000035262","variation_archive_id":"VCV000013972","internal_id":"35262","version":"6","title":"BRAF, ASP594GLY_LYMPHOMA, NON-HODGKIN, SOMATIC","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"3352","review_status":"no assertion criteria provided","submission_names":[]}
{"date_created":"2013-03-26","rcv_accession_id":"RCV000034388","record_status":"current","interpretation_description":"variant of unknown significance","submitter_id":"1160","clinical_assertion_observation_ids":["SCV000043125.0"],"variation_id":"822","interpretation_date_last_evaluated":"2012-07-13","submission_id":"1160.2012-07-15","clinical_assertion_trait_set_id":"SCV000043125","interpretation_comments":["{\"text\":\"Converted during submission to Uncertain significance.\",\"type\":\"ConvertedByNCBI\"}"],"content":"{\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"22703879\",\"@Source\":\"PubMed\"}},\"StudyName\":{\"$\":\"ClinSeq\"}}","local_key":"NM_000038.4:c.3920T\u003eA|not provided","id":"SCV000043125","variation_archive_id":"VCV000000822","internal_id":"98286","version":"1","date_last_updated":"2019-05-02","assertion_type":"variation to disease","trait_set_id":"9460","review_status":"no assertion criteria provided","submission_names":["ClinSeq_cancer"]}
{"date_created":"2018-01-04","rcv_accession_id":"RCV000020088","record_status":"current","interpretation_description":"Likely pathogenic","submitter_id":"320494","clinical_assertion_observation_ids":["SCV000677724.0"],"variation_id":"822","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-09-27","submission_id":"320494.2017-06-22","clinical_assertion_trait_set_id":"SCV000677724","interpretation_comments":["{\"text\":\"I1307K is associated with a 10-20% lifetime risk of developing colon cancer in individuals of Ashkenazi Jewish ancestry and is not known to cause classic or attenuated FAP.\",\"type\":\"public\"}"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Counsyl Autosomal Dominant Disease Classification criteria (2015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/soovr93u/mdi-5618_320494_counsyl_autosomal_dominant_disease_classification_criteria_%25282015%2529_v1.pdf\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"23576677\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24310308\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9288102\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23896379\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"17854661\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24728327\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"15712637\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9724771\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24599579\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24416237\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22703879\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"11001924\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18343606\",\"@Source\":\"PubMed\"}}]}}","local_key":"76464|OMIM:175100","id":"SCV000677724","variation_archive_id":"VCV000000822","internal_id":"1328882","version":"1","date_last_updated":"2019-05-02","assertion_type":"variation to disease","trait_set_id":"6265","review_status":"criteria provided, single submitter","submission_names":["SUB2805501"]}
{"date_created":"2018-03-15","rcv_accession_id":"RCV000000864","record_status":"current","interpretation_description":"Uncertain significance","submitter_id":"500026","clinical_assertion_observation_ids":["SCV000694042.0"],"variation_id":"822","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-12-02","submission_id":"500026.2018-01-25","clinical_assertion_trait_set_id":"SCV000694042","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"LabCorp Variant Classification Summary - May 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"LabCorp Variant Classification Summary - May 2015.docx\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/pttb9itm/labcorp_variant_classification_method_-_may_2015.pdf\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"24416237\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26421687\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26394139\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23576677\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9288102\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18343606\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9751605\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26300997\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26845104\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24599579\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22703879\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9973276\",\"@Source\":\"PubMed\"}}]}}","local_key":"NM_000038.5:c.3920T\u003eA|MedGen:CN221809","id":"SCV000694042","variation_archive_id":"VCV000000822","internal_id":"1360394","version":"1","date_last_updated":"2019-05-02","assertion_type":"variation to disease","trait_set_id":"215","review_status":"criteria provided, single submitter","submission_names":["2016-2017-variants"]}
{"date_created":"2011-05-06","rcv_accession_id":"RCV000020088","record_status":"current","interpretation_description":"pathologic","submitter_id":"500062","clinical_assertion_observation_ids":["SCV000040392.0"],"variation_id":"822","interpretation_date_last_evaluated":"2011-10-27","submission_id":"500062.2013-01-08","clinical_assertion_trait_set_id":"SCV000040392","interpretation_comments":["{\"text\":\"Converted during submission to Pathogenic.\",\"type\":\"ConvertedByNCBI\"}"],"local_key":"NM_000038.3:c.3920T\u003eA_NBK1345","id":"SCV000040392","variation_archive_id":"VCV000000822","internal_id":"40392","version":"1","title":"NM_000038.3:c.3920T\u003eA and APC-Associated Polyposis Conditions","date_last_updated":"2019-05-19","assertion_type":"variation to disease","trait_set_id":"6265","review_status":"no assertion criteria provided","submission_names":[]}
{"date_created":"2018-10-11","rcv_accession_id":"RCV000020088","record_status":"current","interpretation_description":"risk factor","submitter_id":"500199","clinical_assertion_observation_ids":["SCV000839876.0"],"variation_id":"822","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2017-06-02","submission_id":"500199.2018-06-14","clinical_assertion_trait_set_id":"SCV000839876","interpretation_comments":["{\"text\":\"The c.3920T\u003eA (p.Ile1307Lys) variant in the APC gene has been reported as a common risk allele associated with familial colorectal cancer in the Ashkenazi Jewish population [PMID 18770064, 24416237]. The c.3920T\u003eA variant has been reported to result in an adenine replacing a thymine and creating an oligo-adenine (A8) tract that appears to be inherently prone to further somatic mis-pairing and slippage during DNA replication, thereby creating a frameshift change [PMID 9288102, 18770064 and 244162370]. However, this variant has also been reported at a high frequency, present in 6% of Ashkenazi Jews and about 28% of Ashkenazim with a family history of colorectal cancer [PMID: 9288102]. Isoleucine at amino acid position 1307 of the APC protein is weakly conserved during evolution. While not validated for clinical use, the SIFT and PolyPhen-2 algorithms predict this variant to be benign. Ashkenazi Jews who carry the p.Ile1307Lys variant are at increased risk for colorectal neoplasia: the risk for colorectal neoplasia in heterozygous Ashkenazi Jewish individuals was estimated to be between 1.7 to 2.17 compared to non carrier individuals [PMID 12173321, 23576677, 23896379]. This variant is classified as as a risk allele with an increased risk for colorectal neoplasia in the Ashkenazi Jewish population. However the risk in non Jewish populations has not been determined.\",\"type\":\"public\"}"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","local_key":"NM_000038.5:c.3920T\u003eA|OMIM:175100","id":"SCV000839876","variation_archive_id":"VCV000000822","internal_id":"1637429","version":"1","date_last_updated":"2019-05-02","assertion_type":"variation to disease","trait_set_id":"6265","review_status":"criteria provided, single submitter","submission_names":["SUB4151980"]}
{"date_created":"2018-10-05","rcv_accession_id":"RCV000115087","record_status":"current","interpretation_description":"risk factor","submitter_id":"505504","clinical_assertion_observation_ids":["SCV000821694.0"],"variation_id":"822","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2018-08-01","submission_id":"505504.2018-08-08","clinical_assertion_trait_set_id":"SCV000821694","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","local_key":"NM_000038.5:c.3920T\u003eA|MedGen:C0027672","id":"SCV000821694","variation_archive_id":"VCV000000822","internal_id":"1609757","version":"1","date_last_updated":"2019-05-02","assertion_type":"variation to disease","trait_set_id":"13598","review_status":"criteria provided, single submitter","submission_names":["SUB4381212"]}
{"date_created":"2016-03-19","rcv_accession_id":"RCV000210085","record_status":"current","interpretation_description":"risk factor","submitter_id":"506834","clinical_assertion_observation_ids":["SCV000266006.0","SCV000266006.1","SCV000266006.2","SCV000266006.3","SCV000266006.4","SCV000266006.5","SCV000266006.6","SCV000266006.7","SCV000266006.8"],"variation_id":"822","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2015-11-20","submission_id":"506834.2016-03-03","clinical_assertion_trait_set_id":"SCV000266006","interpretation_comments":["{\"text\":\"Low penetrance mutation that is associated with a small increase in risk of colon cancer and with an increased risk of colon polyps (Boursi 2013)\",\"type\":\"public\"}"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Shirts et al. (Genet Med 2016)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"26845104\",\"@Source\":\"PubMed\"}}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"}}","local_key":"c.3920T\u003eA","id":"SCV000266006","variation_archive_id":"VCV000000822","internal_id":"498299","version":"1","date_last_updated":"2019-05-02","assertion_type":"variation to disease","trait_set_id":"1570","review_status":"criteria provided, single submitter","submission_names":["GIM_BROCA"]}
{"date_created":"2017-09-27","rcv_accession_id":"RCV000034388","record_status":"current","interpretation_description":"Likely benign","submitter_id":"25969","clinical_assertion_observation_ids":["SCV000602533.0"],"variation_id":"822","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2018-06-20","submission_id":"25969.2018-10-10","clinical_assertion_trait_set_id":"SCV000602533","interpretation_comments":["{\"text\":\"The APC c.3920T\u003eA; p.Ile1307Lys variant has been reported extensively in the literature. One recent meta-analysis of 30 published population studies, all of which examined the association between p.Ile1307Lys and colorectal neoplasia, colorectal adenoma, and/or colorectal cancer, concluded that this variant confers a two-fold increased risk of developing a colorectal neoplasia to persons of Ashkenazi Jewish ancestry (Liang 2013 and references therein). However, the c.3920T\u003eA;p.Ile1307Lys variant is observed in the general population at an overall frequency of 0.18% (506/276756 alleles, 6 homozygotes) in the Genome Aggregation Database. Due to the high frequency in the general population, this variant is considered likely benign. REFERENCES Liang et al. APC polymorphisms and the risk of colorectal neoplasia: a HuGE review and meta-analysis. Am J Epidemiol. 2013;177(11):1169-1179.\",\"type\":\"public\"}"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ARUP Molecular Germline Variant Investigation Process\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/nr7Bh7s8/ARUP_MolecularGermlineVariantInvestigationProcess.pdf\"}}}}","local_key":"11931|Not Provided","id":"SCV000602533","variation_archive_id":"VCV000000822","internal_id":"1166229","version":"2","date_last_updated":"2019-05-27","assertion_type":"variation to disease","trait_set_id":"9460","review_status":"criteria provided, single submitter","submission_names":["SUB4618058"]}
{"date_created":"2018-10-05","rcv_accession_id":"RCV000020088","record_status":"current","interpretation_description":"Likely pathogenic","submitter_id":"500035","clinical_assertion_observation_ids":["SCV000838110.0"],"variation_id":"822","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2018-07-02","submission_id":"500035.2018-11-11","clinical_assertion_trait_set_id":"SCV000838110","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Mendelics Assertion Criteria 2017\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/chhjzatu/mendelics_assertion_criteria_2017.pdf\"}}}}","local_key":"NC_000005.9:g.112175211T\u003eA|MedGen:C2713442","id":"SCV000838110","variation_archive_id":"VCV000000822","internal_id":"1610680","version":"2","date_last_updated":"2019-05-02","assertion_type":"variation to disease","trait_set_id":"6265","review_status":"criteria provided, single submitter","submission_names":["MENDELICS_CLINVAR_015"]}
{"date_created":"2018-02-16","rcv_accession_id":"RCV000115087","record_status":"current","interpretation_description":"Likely pathogenic","submitter_id":"505849","clinical_assertion_observation_ids":["SCV000686956.0"],"variation_id":"822","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2018-05-21","submission_id":"505849.2018-11-06","clinical_assertion_trait_set_id":"SCV000686956","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","local_key":"Db4KrQBSZeoE7-orUyypkal4dklV7Tc_lQTp9W4PGUo|MedGen:C0027672","id":"SCV000686956","variation_archive_id":"VCV000000822","internal_id":"1344252","version":"2","date_last_updated":"2019-05-20","assertion_type":"variation to disease","trait_set_id":"13598","review_status":"criteria provided, single submitter","submission_names":["SUB4721021"]}
{"date_created":"2011-01-25","rcv_accession_id":"RCV000000864","record_status":"current","interpretation_description":"risk factor","submitter_id":"3","clinical_assertion_observation_ids":["SCV000021014.0"],"variation_id":"822","interpretation_date_last_evaluated":"2019-04-01","submission_id":"3.2014-02-19","clinical_assertion_trait_set_id":"SCV000021014","interpretation_comments":[],"local_key":"611731.0029_FAMILIAL ADENOMATOUS POLYPOSIS 1, SUSCEPTIBILITY TO","id":"SCV000021014","variation_archive_id":"VCV000000822","internal_id":"21014","version":"3","title":"APC, ILE1307LYS_FAMILIAL ADENOMATOUS POLYPOSIS 1, SUSCEPTIBILITY TO","date_last_updated":"2019-05-02","assertion_type":"variation to disease","trait_set_id":"215","review_status":"no assertion criteria provided","submission_names":[]}
{"date_created":"2014-08-01","rcv_accession_id":"RCV000115087","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"61756","clinical_assertion_observation_ids":["SCV000183892.0"],"variation_id":"822","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2018-02-28","submission_id":"61756.2018-07-30","clinical_assertion_trait_set_id":"SCV000183892","interpretation_comments":["{\"text\":\"Lines of evidence used in support of classification: Significant disease association in appropriately sized case-control study(ies),Detected in individual satisfying established diagnostic critera for classic disease without a clear mutation,Other strong data supporting pathogenic classification\",\"type\":\"public\"}"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Ambry Autosomal Dominant and X-Linked criteria (3/2017)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/10Jq49tz/AD_XL_ClassificationScheme_03.2017_Ambry.pdf\"}}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"23576677\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16228836\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23896379\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24728327\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18343606\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9288102\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26421687\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9973276\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"11159880\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"10938175\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26314409\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27146957\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27153395\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28135145\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28125075\",\"@Source\":\"PubMed\"}}]}}","local_key":"a4793","id":"SCV000183892","variation_archive_id":"VCV000000822","internal_id":"302407","version":"7","date_last_updated":"2019-05-02","assertion_type":"variation to disease","trait_set_id":"13598","review_status":"criteria provided, single submitter","submission_names":["SUB4348735"]}
{"date_created":"2017-04-13","rcv_accession_id":"RCV000476410","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"1006","clinical_assertion_observation_ids":["SCV000540939.0"],"variation_id":"17674","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2017-02-23","submission_id":"1006.2017-02-23","clinical_assertion_trait_set_id":"SCV000540939","interpretation_comments":[],"content":"{\"AttributeSet\":[{\"Attribute\":{\"$\":\"Autosomal dominant inheritance\",\"@Type\":\"ModeOfInheritance\"}},{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}],\"StudyDescription\":{\"$\":\"Variants for BRCA1/2 tests\"}}","local_key":"NM_007294.3:c.4065_4068delTCAA|Familial cancer of breast","id":"SCV000540939","variation_archive_id":"VCV000017674","internal_id":"1053858","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"774","review_status":"criteria provided, single submitter","submission_names":["BRCA12"]}
{"date_created":"2015-03-28","rcv_accession_id":"RCV000019243","record_status":"current","interpretation_description":"Likely pathogenic","submitter_id":"320494","clinical_assertion_observation_ids":["SCV000220878.0"],"variation_id":"17674","interpretation_date_last_evaluated":"2014-11-14","submission_id":"320494.2015-03-11","clinical_assertion_trait_set_id":"SCV000220878","interpretation_comments":[],"content":"{\"AttributeSet\":[{\"Attribute\":{\"$\":\"Autosomal dominant inheritance\",\"@Type\":\"ModeOfInheritance\"}},{\"Attribute\":{\"$\":\"Counsyl Autosomal Dominant Disease Classification criteria (2015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"Counsyl Autosomal Dominant Disease Classification criteria (2015)\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/soovr93u/mdi-5618_320494_counsyl_autosomal_dominant_disease_classification_criteria_(2015)_v1.pdf\"}}}],\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"21559243\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"11802209\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23683081\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24549055\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23633455\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"17018160\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"21324516\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"7894493\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24556621\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"14757871\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23175448\",\"@Source\":\"PubMed\"}}]}}","local_key":"NM_007294.3(BRCA1):c.4065_4068delTCAA","id":"SCV000220878","variation_archive_id":"VCV000017674","internal_id":"397634","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"1917","review_status":"criteria provided, single submitter","submission_names":["Counsyl_2015_03_01"]}
{"date_created":"2018-03-15","rcv_accession_id":"RCV000048431","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"500026","clinical_assertion_observation_ids":["SCV000699105.0"],"variation_id":"17674","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2017-08-22","submission_id":"500026.2018-01-25","clinical_assertion_trait_set_id":"SCV000699105","interpretation_comments":["{\"text\":\"Variant summary: The BRCA1 c.4065_4068delTCAA (p.Asn1355Lysfs) variant results in a premature termination codon, predicted to cause a truncated or absent BRCA1 protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory (e.g. c.4117G\u003eT, p.Glu1373X; c.4158_4162delCTCTC, p.Ser1387fs). This variant has been reported in numerous HBOC patients with positive family history (e.g. Langston 1996, Spitzer 2000, Evans 2004, Borg 2010). This variant is absent in 121322 control chromosomes, suggesting that it is not a common, benign variant. In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as pathogenic. Taken together, this variant is classified as pathogenic.\",\"type\":\"public\"}"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"LabCorp Variant Classification Summary - May 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"LabCorp Variant Classification Summary - May 2015.docx\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/pttb9itm/labcorp_variant_classification_method_-_may_2015.pdf\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"8531967\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"14757871\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20104584\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"10699917\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"21702907\",\"@Source\":\"PubMed\"}}]}}","local_key":"NM_007294.3:c.4065_4068delTCAA|MedGen:C0677776","id":"SCV000699105","variation_archive_id":"VCV000017674","internal_id":"1365457","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"7920","review_status":"criteria provided, single submitter","submission_names":["2016-2017-variants"]}
{"date_created":"2018-10-05","rcv_accession_id":"RCV000048431","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"500035","clinical_assertion_observation_ids":["SCV000839242.0"],"variation_id":"17674","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2018-07-02","submission_id":"500035.2018-08-20","clinical_assertion_trait_set_id":"SCV000839242","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Mendelics Assertion Criteria 2017\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/chhjzatu/mendelics_assertion_criteria_2017.pdf\"}}}}","local_key":"NC_000017.10:g.41243480_41243483delTTGA|MedGen:C0677776","id":"SCV000839242","variation_archive_id":"VCV000017674","internal_id":"1611812","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"7920","review_status":"criteria provided, single submitter","submission_names":["SUB4427121"]}
{"date_created":"2016-07-29","rcv_accession_id":"RCV000238776","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"505504","clinical_assertion_observation_ids":["SCV000296801.0"],"variation_id":"17674","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-07-01","submission_id":"505504.2016-07-19","clinical_assertion_trait_set_id":"SCV000296801","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","local_key":"NM_007294.3:c.4065_4068delTCAA|MedGen:CN169374","id":"SCV000296801","variation_archive_id":"VCV000017674","internal_id":"574372","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"9590","review_status":"criteria provided, single submitter","submission_names":[]}
{"date_created":"2017-07-26","rcv_accession_id":"RCV000019243","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"505785","clinical_assertion_observation_ids":["SCV000584013.0"],"variation_id":"17674","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2017-07-21","submission_id":"505785.2017-07-24","clinical_assertion_trait_set_id":"SCV000584013","interpretation_comments":[],"content":"{\"AttributeSet\":[{\"Attribute\":{\"$\":\"Autosomal dominant inheritance\",\"@Type\":\"ModeOfInheritance\"}},{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}],\"Citation\":[{\"@Type\":\"general\",\"ID\":{\"$\":\"11802209\",\"@Source\":\"PubMed\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"12402332\",\"@Source\":\"PubMed\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"12698193\",\"@Source\":\"PubMed\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"9649133\",\"@Source\":\"PubMed\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"3405339\",\"@Source\":\"pmc\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"8571953\",\"@Source\":\"PubMed\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"9150148\",\"@Source\":\"PubMed\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"3893336\",\"@Source\":\"pmc\"}}]}","local_key":"SUB2892902","id":"SCV000584013","variation_archive_id":"VCV000017674","internal_id":"1139118","version":"1","title":"SUB2892902","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"1917","review_status":"criteria provided, single submitter","submission_names":["SUB2892902"]}
{"date_created":"2017-08-25","rcv_accession_id":"RCV000048431","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"506152","clinical_assertion_observation_ids":["SCV000591484.0"],"variation_id":"17674","submitted_assembly":"GRCh37","submission_id":"506152.2017-04-19","clinical_assertion_trait_set_id":"SCV000591484","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}},\"StudyName\":{\"$\":\"The Canadian Open Genetics Repository (COGR)\"}}","local_key":"NM_007294.3:c.4065_4068delTCAA|MedGen:C0677776","id":"SCV000591484","variation_archive_id":"VCV000017674","internal_id":"1147928","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"7920","review_status":"criteria provided, single submitter","submission_names":["SHS20170111"]}
{"date_created":"2018-04-18","rcv_accession_id":"RCV000019243","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"506497","clinical_assertion_observation_ids":["SCV000744620.0"],"variation_id":"17674","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2017-05-31","submission_id":"506497.2018-04-09","clinical_assertion_trait_set_id":"SCV000744620","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACGS Guidelines, 2013\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/3yyso7ro/evaluation_and_reporting_of_sequence_variants_bpgs_june_2013_-_finalpdf.pdf\"}}},\"StudyName\":{\"$\":\"VKGL Data-share Consensus\"}}","local_key":"NM_007294.3:c.4065_4068delTCAA|OMIM:604370","id":"SCV000744620","variation_archive_id":"VCV000017674","internal_id":"1451074","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"1917","review_status":"criteria provided, single submitter","submission_names":["SUB3885264"]}
{"date_created":"2014-03-30","rcv_accession_id":"RCV000019243","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"504196","clinical_assertion_observation_ids":["SCV000144954.0","SCV000144954.1","SCV000144954.2","SCV000144954.3","SCV000144954.4","SCV000144954.5","SCV000144954.6","SCV000144954.7","SCV000144954.8","SCV000144954.9","SCV000144954.10","SCV000144954.11","SCV000144954.12","SCV000144954.13","SCV000144954.14","SCV000144954.15","SCV000144954.16","SCV000144954.17","SCV000144954.18","SCV000144954.19","SCV000144954.20","SCV000144954.21","SCV000144954.22","SCV000144954.23","SCV000144954.24","SCV000144954.25"],"variation_id":"17674","interpretation_date_last_evaluated":"2002-05-29","submission_id":"504196.2014-03-28","clinical_assertion_trait_set_id":"SCV000144954","interpretation_comments":[],"local_key":"U14680.1:n.4184_4187delTCAA|MedGen:C2676676","id":"SCV000144954","variation_archive_id":"VCV000017674","internal_id":"261852","version":"2","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"1917","review_status":"no assertion criteria provided","submission_names":[]}
{"date_created":"2015-03-28","rcv_accession_id":"RCV000048431","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"1050","clinical_assertion_observation_ids":["SCV000219238.0"],"variation_id":"17674","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2017-02-01","submission_id":"1050.2017-08-28","clinical_assertion_trait_set_id":"SCV000219238","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}},\"StudyName\":{\"$\":\"The Canadian Open Genetics Repository (COGR)\"}}","local_key":"1776816|Orphanet:ORPHA145","id":"SCV000219238","variation_archive_id":"VCV000017674","internal_id":"395994","version":"3","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"7920","review_status":"criteria provided, single submitter","submission_names":["CHEO20170828_update"]}
{"date_created":"2016-11-04","rcv_accession_id":"RCV000019243","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"505954","clinical_assertion_observation_ids":["SCV000325829.0"],"variation_id":"17674","submitted_assembly":"hg18","interpretation_date_last_evaluated":"2015-10-02","submission_id":"505954.2016-10-28","clinical_assertion_trait_set_id":"SCV000325829","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"CIMBA Mutation Classification guidelines May 2016\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"CIMBA_Mutation_Classification_guidelines_May16.pdf\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/MIHuUwlX/CIMBA_Mutation_Classification_guidelines_May16.pdf\"}}}}","local_key":"NM_007294.3:c.4065_4068del|OMIM:604370","id":"SCV000325829","variation_archive_id":"VCV000017674","internal_id":"624937","version":"3","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"1917","review_status":"criteria provided, single submitter","submission_names":["CIMBA_20161005"]}
{"date_created":"2012-11-07","rcv_accession_id":"RCV000019243","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"500037","clinical_assertion_observation_ids":["SCV000053742.0"],"variation_id":"17674","interpretation_date_last_evaluated":"2013-03-21","submission_id":"500037.2015-12-29","clinical_assertion_trait_set_id":"SCV000053742","interpretation_comments":[],"local_key":"SCRP_var_186","id":"SCV000053742","variation_archive_id":"VCV000017674","internal_id":"89357","version":"6","title":"NM_007294.3:c.4065_4068delTCAA AND Breast-ovarian cancer, familial 1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"1917","review_status":"no assertion criteria provided","submission_names":[]}
{"date_created":"2013-07-02","rcv_accession_id":"RCV000048431","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"500031","clinical_assertion_observation_ids":["SCV000076444.0"],"variation_id":"17674","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2018-06-29","submission_id":"500031.2018-08-29","clinical_assertion_trait_set_id":"SCV000076444","interpretation_comments":["{\"text\":\"This sequence change creates a premature translational stop signal (p.Asn1355Lysfs*10) in the BRCA1 gene. It is expected to result in an absent or disrupted protein product. This variant is present in population databases (rs80357508, ExAC 0.006%). This variant has been reported in multiple individuals and families affected with breast and ovarian cancer (PMID: 14757871, 8571953, 11802209, 21559243). This variant is also known as 4184del4 in the literature. ClinVar contains an entry for this variant (Variation ID: 17674). Loss-of-function variants in BRCA1 are known to be pathogenic (PMID: 20104584). For these reasons, this variant has been classified as Pathogenic.\",\"type\":\"public\"}"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Nykamp K et al. (Genet Med 2017)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}}},\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"14757871\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"21559243\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"8571953\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"11802209\",\"@Source\":\"PubMed\"}}]}}","local_key":"306942|MedGen:C0677776","id":"SCV000076444","variation_archive_id":"VCV000017674","internal_id":"124374","version":"10","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"7920","review_status":"criteria provided, single submitter","submission_names":["SUB4474525"]}
{"date_created":"2018-07-27","rcv_accession_id":"RCV000664336","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"506018","clinical_assertion_observation_ids":["SCV000788260.0"],"variation_id":"549768","submitted_assembly":"not applicable","interpretation_date_last_evaluated":"2018-05-04","submission_id":"506018.2018-05-10","clinical_assertion_trait_set_id":"SCV000788260","interpretation_comments":["{\"text\":\"The p.V292M/R67H/R982C allele was found in trans with p.C634Y in a Chinese family, genotype c.[1901G\u003eA];[200G\u003eA;874G\u003eA;2944C\u003eT]. One family member had both variant RET alleles and MTC onset at 13 yrs. Family members with only the p.C634Y mutation had MEN2A. Family members with the p.V292M/R67H/R982C allele had MTC (70 yr) and C-cell hyperplasia (44 yr). Variants p.R67H and p.R982C are common and likely benign, GnomAD frequency 0.1% and 2%, respectively (gnomad.broadinstitute.org/gene/ENSG00000165731). For reports of p.V292M alone, see c.874G\u003eA.\",\"type\":\"public\"}"],"content":"{\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"21655256\",\"@Source\":\"PubMed\"}},{\"URL\":{\"$\":\"http://www.arup.utah.edu/database/MEN2/MEN2_display.php\"}}]}}","local_key":"6|MedGen:CN073359","id":"SCV000788260","variation_archive_id":"VCV000549768","internal_id":"1538355","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"8702","review_status":"no assertion criteria provided","submission_names":["MEN2 update May 2018"]}
{"date_created":"2019-06-14","rcv_accession_id":"RCV000785337","record_status":"current","interpretation_description":"Likely pathogenic","submitter_id":"506864","clinical_assertion_observation_ids":["SCV000923905.0"],"variation_id":"481015","submitted_assembly":"GRCh38","interpretation_date_last_evaluated":"2018-12-01","submission_id":"506864.2019-02-22","clinical_assertion_trait_set_id":"SCV000923905","interpretation_comments":[],"local_key":"NM_000546.5:c.375+5G\u003eA|MeSH:D010051","id":"SCV000923905","variation_archive_id":"VCV000481015","internal_id":"1803473","version":"1","date_last_updated":"2019-06-18","assertion_type":"variation to disease","trait_set_id":"35155","review_status":"no assertion criteria provided","submission_names":["SUB5218044"]}
{"date_created":"2018-04-03","rcv_accession_id":"RCV000614433","record_status":"current","interpretation_description":"Likely benign","submitter_id":"21766","clinical_assertion_observation_ids":["SCV000711777.0"],"variation_id":"504895","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-04-14","submission_id":"21766.2018-02-23","clinical_assertion_trait_set_id":"SCV000711777","interpretation_comments":["{\"text\":\"c.2232+9C\u003eT in intron 18 of MYH14: This variant is not expected to have clinical significance because it does not alter an amino acid residue and is not located within the splice consensus sequence.\",\"type\":\"public\"}"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"LMM Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"24033266\",\"@Source\":\"PubMed\"}}}}","local_key":"66138958|not specified","id":"SCV000711777","variation_archive_id":"VCV000504895","internal_id":"1392883","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"9590","review_status":"criteria provided, single submitter","submission_names":["SUB3719835"]}
{"date_created":"2017-01-11","rcv_accession_id":"RCV000415452","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"1006","clinical_assertion_observation_ids":["SCV000328841.0"],"variation_id":"374401","submitted_assembly":"hg19","interpretation_date_last_evaluated":"2014-06-17","submission_id":"1006.2016-11-14","clinical_assertion_trait_set_id":"SCV000328841","interpretation_comments":["{\"text\":\"Our laboratory reported dual molecular diagnoses in PLA2G6 (homozygous exon 2 deletion) and BCAP31 (NM_001139457.2, c.107C\u003eA) in one individual with reported features which included delayed motor milestones, developmental regression, dysphagia, central hypotonia, vision loss, esotropia, cryptorchidism, cerebellar atrophy with a flattened pons and hypoplasia of the inferior vermis. The BCAP31 variant is predicted to cause a nonsense mutation and is categorized as deleterious by ACMGG guidelines [PMID: 18414213].\",\"type\":\"public\"}"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"X-linked inheritance\",\"@Type\":\"ModeOfInheritance\"}}}","local_key":"chrX:152989013G\u003eT|OMIM:300475","id":"SCV000328841","variation_archive_id":"VCV000374401","internal_id":"962969","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"11792","review_status":"no assertion criteria provided","submission_names":["Dual_diagnosis_variants"]}
{"date_created":"2018-12-11","rcv_accession_id":"RCV000223898","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"500060","clinical_assertion_observation_ids":["SCV000862304.0"],"variation_id":"42540","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2018-07-10","submission_id":"500060.2018-09-19","clinical_assertion_trait_set_id":"SCV000862304","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"EGL_ClinVar_v180209_classification definitions\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/leconafi/egl_clinvar_v180209_classification_definitions.pdf\"}}},\"Citation\":{\"URL\":{\"$\":\"http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=MYBPC3\"}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"22267749\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"12707239\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"19574547\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20378854\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23642604\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"29121657\",\"@Source\":\"PubMed\"}}]}}","local_key":"71108_000000","id":"SCV000862304","variation_archive_id":"VCV000042540","internal_id":"1679294","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"9460","review_status":"criteria provided, single submitter","submission_names":["SUB4534263"]}
{"date_created":"2018-02-23","rcv_accession_id":"RCV000584810","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"505375","clinical_assertion_observation_ids":["SCV000692517.0"],"variation_id":"42540","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2017-03-16","submission_id":"505375.2017-12-19","clinical_assertion_trait_set_id":"SCV000692517","interpretation_comments":["{\"text\":\"The MYBPC3 Arg502Trp s a well known cause of HCM, being reported in multiple HCM cases worldwide and segregating with HCM in families (see Ross et al. Circulation CV Genetics, 2017). The variant is present in the Exome Aggregation Consortium dataset (MAF=0.000025; http://exac.broadinstitute.org/). We have identified this variant in 14 HCM families with some segregation data (total of 7 meiosis). Computational tools SIFT, PolyPhen-2 and MutationTaster predict this variant to be deleterious. In summary, based on segregation, extensive reports of HCM cases with the variant and rarity in the general population, we classify MYBPC3 Arg502Trp as \\\"Pathogenic\\\".\",\"type\":\"public\"}"],"content":"{\"AttributeSet\":[{\"Attribute\":{\"$\":\"Autosomal dominant inheritance\",\"@Type\":\"ModeOfInheritance\"}},{\"Attribute\":{\"$\":\"Agnes Ginges Centre for Molecular Cardiology criteria (2015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/djgybgii/mdi-5363_505375_agnesginges_variantassess_clinvar.pdf\"}}}],\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"20378854\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20031618\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"19574547\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18809796\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16199542\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"15519027\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"12707239\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18403758\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23690394\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"21839045\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22563033\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24810389\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22267749\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18761664\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20818890\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27532257\",\"@Source\":\"PubMed\"}}]}}","local_key":"VAR0000100|OMIM:192600","id":"SCV000692517","variation_archive_id":"VCV000042540","internal_id":"1353547","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"6411","review_status":"criteria provided, single submitter","submission_names":["SUB3353316"]}
{"date_created":"2016-06-01","rcv_accession_id":"RCV000223898","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"505443","clinical_assertion_observation_ids":["SCV000280214.0"],"variation_id":"42540","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2014-07-08","submission_id":"505443.2016-05-06","clinical_assertion_trait_set_id":"SCV000280214","interpretation_comments":["{\"text\":\"Note this variant was found in clinical genetic testing performed by one or more labs who may also submit to ClinVar. Thus any internal case data may overlap with the internal case data of other labs. The interpretation reviewed below is that of the Stanford Center for Inherited Cardiovascular Disease. MYBPC3 p.Arg502Trp This variant has been reported in at least 37 cases of HCM, with strong segregation data. Richard et al (2003) reported this variant in one individual with HCM in their French cohort. Van Driest et al (2004) observed this variant in an HCM patient who also carried p.Gly5Arg in MYBPC3. Details regarding phase and the severity of phenotype were not reported for this patient However, a comparison of the 10 patients, including this one, with multiple variants to the patients with a single variant revealed that the multiple variant group had, on average, a more severe phenotype. Ingles et al (2005) reported observing this variant in one case of HCM. Saltzman et al (2010) reported p.Arg502Trp in 34 of 1414 (2.4%) unrelated cases of HCM, making it the most common variant in that cohort. Four families had another sarcomere variant and individuals with multiple variants were more likely to have severe clinical outcomes. They noted that ~50% of carriers of p.Arg502Trp had overt disease by age 45. They reported a combined Lod score of 4.04 and noted that the likelihood that the observed cosegregation happened by chance was 1/11,000. The highest number of family members cosegregating HCM and the variant in one individual family was three. Note that this paper includes a pedigree reported online by the Seidman group (pedigree FU). Morita et al (2008) observed the variant in two unrelated children with HCM. In one of those cases and affected parent also had the variant. One of these children also carried p.Ser858Asn in MYBPC3 (phase not reported) Note that these families may have been included in the subsequent report by Saltzman et al. Liu et al (2006) reported a Chinese patient with HCM who carried both p.Arg502Trp and IVS27+12C\u003eT, also in MYBPC3. The arginine at codon 502 is highly conserved across species. This mutation results in a non-conservative amino acid change of a positively charged Arginine residue with a non-polar Tryptophan. In silico analysis with PolyPhen-2 predicts the variant to be probably damaging. Another variant at the same codon has been reported in association with HCM (p.Arg502Gln, which we consider very likely disease causing), as have variants in nearby codons (p.Arg495Gln, p.Lys505del, p.Gly507Arg). In total the variant has not been seen in ~395 published controls, including 100 (Richard et al 2003), 200 (van Driest et al 2004), 95 (Saltzman et al 2010). The variant was observed in 1 of 3472 Caucasians and 0 of 1826 African Americans in the NHLBI Exome Sequence Project dataset (as of 7/8/2014). Individual phenotypes from that dataset are not available. Several different cohorts from studies on common complex cardiovascular disease were pooled to create that sample. There is no variant at codon 502 listed in dbSNP or 1000 genomes (as of 7/8/2014).\",\"type\":\"public\"}"],"local_key":"NM_000256.3:c.1504C\u003eT|Not provided","id":"SCV000280214","variation_archive_id":"VCV000042540","internal_id":"528700","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"9460","review_status":"no assertion criteria provided","submission_names":["5_6_2016"]}
{"date_created":"2016-12-02","rcv_accession_id":"RCV000403323","record_status":"current","interpretation_description":"Uncertain significance","submitter_id":"504895","clinical_assertion_observation_ids":["SCV000372356.0"],"variation_id":"42540","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-06-14","submission_id":"504895.2016-10-18","clinical_assertion_trait_set_id":"SCV000372356","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification 20161018\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"ICSL_Variant_Classification_20161018.pdf\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/4jQgNGYk/ICSL_Variant_Classification_20161018.pdf\"}}}}","local_key":"786202|Dilated Cardiomyopathy, Dominant","id":"SCV000372356","variation_archive_id":"VCV000042540","internal_id":"685878","version":"2","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"33381","review_status":"criteria provided, single submitter","submission_names":["ICSL_2016Q4"]}
{"date_created":"2016-12-02","rcv_accession_id":"RCV000351173","record_status":"current","interpretation_description":"Uncertain significance","submitter_id":"504895","clinical_assertion_observation_ids":["SCV000372355.0"],"variation_id":"42540","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-06-14","submission_id":"504895.2016-10-18","clinical_assertion_trait_set_id":"SCV000372355","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification 20161018\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"ICSL_Variant_Classification_20161018.pdf\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/4jQgNGYk/ICSL_Variant_Classification_20161018.pdf\"}}}}","local_key":"786202|Left Ventricular Noncompaction Cardiomyopathy","id":"SCV000372355","variation_archive_id":"VCV000042540","internal_id":"685877","version":"2","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"19227","review_status":"criteria provided, single submitter","submission_names":["ICSL_2016Q4"]}
{"date_created":"2016-12-02","rcv_accession_id":"RCV000778104","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"504895","clinical_assertion_observation_ids":["SCV000372357.0"],"variation_id":"42540","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2018-05-07","submission_id":"504895.2019-02-01","clinical_assertion_trait_set_id":"SCV000372357","interpretation_comments":["{\"text\":\"The MYBPC3 c.1504C\u003eT (p.Arg502Trp) missense variant is well documented as a pathogenic variant for hypertrophic cardiomyopathy (HCM). Across a selection of the available literature, the p.Arg502Trp variant has been identified in heterozygous state in at least 44 individuals diagnosed with HCM. Two of the individuals carried another variant in the MYBPC3 gene in a compound heterozygous state with the p.Arg502Trp variant, and another 11 carried an additional variant in either MYBPC3 or another sarcomere gene (Richard et al. 2003; Van Driest et al. 2004; Ingles et al. 2005; Maron et al. 2008; Marston et al. 2009; Saltzman et al. 2010; Kaski et al. 2012; Lopes et al. 2013; Camuglia et al. 2013). The Arg502Trp variant has also been reported in a heterozygous state in three individuals diagnosed with left ventricular noncompaction cardiomyopathy. One of the individuals was the son of a female proband with HCM who also carried the variant in a heterozygous state. The two other individuals were the brother and nephew of another proband with HCM who also carried the variant in a heterozygous state (Camuglia et al. 2013). The p.Arg502Trp variant was absent from 945 controls (Van Driest et al. 2004; Saltzman et al. 2010) and is reported at a frequency of 0.0001026 in the European (non-Finnish) population of the Genome Aggregation Database. The variant has been shown to segregate with disease in multiple families (Saltzman et al. 2010). Based on the collective evidence, the p.Arg502Trp variant is classified as pathogenic for MYBPC3-related disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.\",\"type\":\"public\"}"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification Criteria 09 May 2019\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/thsgk7t4/icsl_variant_classification_criteria_09_may_2019.pdf\"}}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"19574547\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20378854\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16199542\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"15519027\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23642604\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18809796\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"12707239\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22589294\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23396983\",\"@Source\":\"PubMed\"}}]}}","local_key":"792361","id":"SCV000372357","variation_archive_id":"VCV000042540","internal_id":"685879","version":"3","date_last_updated":"2019-05-24","assertion_type":"variation to disease","trait_set_id":"33478","review_status":"criteria provided, single submitter","submission_names":["SUB5118208"]}
{"date_created":"2013-03-16","rcv_accession_id":"RCV000035406","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"21766","clinical_assertion_observation_ids":["SCV000059054.0"],"variation_id":"42540","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-07-21","submission_id":"21766.2018-02-23","clinical_assertion_trait_set_id":"SCV000059054","interpretation_comments":["{\"text\":\"The p.Arg502Trp variant in MYBPC3 has been well reported in many individuals across multiple studies and is known to be pathogenic for HCM. This variant meets criteria to be classified as pathogenic based upon extensive segregation studies and functional evidence (Richard 2003, Van Driest 2004, Carballo 2005, Ingles 2005, Maron 2008, Kaski 2009, Marston 2009, Saltzman 2010). It is also the most common pathogenic HCM variant identified by our laboratory.\",\"type\":\"public\"}"],"content":"{\"AttributeSet\":[{\"Attribute\":{\"$\":\"Autosomal dominant inheritance\",\"@Type\":\"ModeOfInheritance\"}},{\"Attribute\":{\"$\":\"LMM Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"24033266\",\"@Source\":\"PubMed\"}}}],\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"16199542\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"15519027\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"12707239\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20378854\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"19574547\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18809796\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20031618\",\"@Source\":\"PubMed\"}}]},\"ReplacedList\":{\"Replaced\":{\"@Accession\":\"SCV000198910\",\"@DateChanged\":\"2015-02-23\",\"@Version\":\"1\"}}}","local_key":"2991309|Orphanet:ORPHA99739","id":"SCV000059054","variation_archive_id":"VCV000042540","internal_id":"100254","version":"5","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"2675","review_status":"criteria provided, single submitter","submission_names":["SUB3719835"]}
{"date_created":"2015-02-19","rcv_accession_id":"RCV000223898","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"26957","clinical_assertion_observation_ids":["SCV000208031.0"],"variation_id":"42540","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2018-12-31","submission_id":"26957.2019-01-29","clinical_assertion_trait_set_id":"SCV000208031","interpretation_comments":["{\"text\":\"The R502W pathogenic variant in the MYBPC3 gene has been reported multiple times in association with HCM (Richard et al., 2003; Van Driest et al., 2004; Ingles et al., 2005; Saltzman et al., 2010; Page et al., 2012; Lopes et al., 2013). This variant has also been observed in multiple unrelated individuals tested for HCM at GeneDx. Richard et al. (2003) identified the R502W variant in one patient with HCM and it was not present in 200 control chromosomes. This study also considered R502 a hot spot\\\" for pathogenic variants because another variant affecting the same residue (R502Q) has also been associated with HCM (Richard et al., 2003; Niimura et al., 1998). Ingles et al. (2005) and Van Driest et al. (2004) observed the R502W variant in one HCM patient each, and the latter publication indicated R502W was not observed in 400 normal control alleles. Page et al. (2012) identified the R502W variant in nine families with HCM, in which variable penetrance and expressivity was observed. This pathogenic variant is observed at a low frequency in large population cohorts, reported in 13/126,700 (0.01%) alleles from individuals of European (non-Finnish) ancestry (Lek et al., 2016). R502W results in a non-conservative amino acid change of a positively charged Arginine residue with a non-polar Tryptophan residue at a position that is highly conserved across species. Functional studies by Zhang et al. (2014) suggested that R502W alters the electrostatic properties of the C3 domain which may disrupt the interaction with other sarcomeric proteins.\\\"\",\"type\":\"public\"}"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"GeneDx Variant Classification (06012015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/7oynscmk/mdi-5616_26957_genedx_interprules_final_061215.pdf\"}}}}","local_key":"GDX:41434|Not Provided","id":"SCV000208031","variation_archive_id":"VCV000042540","internal_id":"373680","version":"11","date_last_updated":"2019-05-09","assertion_type":"variation to disease","trait_set_id":"9460","review_status":"criteria provided, single submitter","submission_names":["SUB5098196"]}
